Cannabinoid conditioned reward and aversion: Behavioral and neural processes

ACS Chemical Neuroscience

Volumn 1, Issue 4, 2010, Pages 265-278

  Murray, Jennifer E ^a,b   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID RECEPTOR; AMIDASE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; CARRIER PROTEIN; COCAINE; DEXANABINOL; DOPAMINE; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; OPIATE;

4 AMINOBUTYRIC ACID RELEASE; AVERSION; CALCIUM CONDUCTANCE; CONDITIONED REFLEX; CONDITIONING; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG SELF ADMINISTRATION; DRUG SPECIFICITY; HEALTH BEHAVIOR; NERVE CELL STIMULATION; NONHUMAN; PLACE PREFERENCE; PROTEIN LOCALIZATION; REVIEW; REWARD;

CANNABIS SATIVA; MUS; RATTUS;

EID: 77951689566     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn100005p     Document Type: Review

References (125)

1. Bardo, M. T. and Bevins, R. A. (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153, 31-43
2. Bevins, R. A. and Cunningham, C. L. (2006) Place Conditioning: A Methodological Analysis, in Tasks and Techniques: A Sampling of the Methodologies for the Investigation of Animal Learning, Behavior and Cognition (Anderson, M. J., Ed.) pp 99 -110, Nova Science Publishers, Inc., New York.
3. Tzschentke, T. M. (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12, 227-462
4. Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure, and partial synthesis of an active constituent of hashish J. Am. Chem. Soc. 86, 1646-1647
5. Devane, W. A., Dysarz, F. A., III, Johnson, M. R., Melvin, L. S., and Howlett, A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain Mol. Pharmacol. 34, 605-613
6. 2 receptors Science 310, 329-332
7. Cabral, G. A. and Dove Pettit, D. A. (1998) Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease J. Immunol. 83, 116-123
8. Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., and Porrino, L. J. (2004) Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 (Suppl 1) 345-358
9. 2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: Focus on G-protein-coupled receptors and transient receptor potential channels. J. Neuroimmune Pharmacol. 5, 103 - 121.
10. De Petrocellis, L., Cascio, M. G., and Di Marzo, V. (2004) The endocannabinoid systerm: a general view and latest additions Br. J. Pharmacol. 141, 765-774
11. Herkenham, M., Lynn, A. B., de Costa, B. R., and Richfield, E. K. (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat Brain Res. 547, 267-274
12. 1 cannabinoid receptor in the rat brain. An immunohistochemical study Peptides 21, 1735-1742
13. Howlett, A. C. (1984) Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds Life Sci. 35, 1803-1810
14. Breivogel, C. S., Sim, L. J., and Childers, S. R. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain J. Pharmacol. Exp. Ther. 282, 1632-1642
15. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E. S., Mackie, K., and Freund, T. F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons J. Neurosci. 19, 4544-4558
16. Katona, I., Rancz, E. A., Acsady, L., Ledent, C., Mackie, K., Hajos, N., and Freund, T. F. (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission J. Neurosci. 21, 9506-9518
17. Mackie, K. and Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neurobalstoma-glioma cells Proc. Natl. Acad. Sci. U.S.A. 89, 3825-3829
18. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J. Neurosci. 15, 6552-6561
19. Alger, B. E. (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids Prog. Neurobiol. 68, 247-286
20. Hashimotodani, Y., Ohno-Shosaku, T., Maejima, T., Fukami, K., and Kano, M. (2008) Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocannabinoids release Neuropharmacology 54, 58-67
21. Adermark, L. and Lovinger, D. M. (2007) Retrograde endocannabinoids signaling at striatal synapses requires a regulated postsynaptic release step Proc. Natl. Acad. Sci. U.S.A. 104, 20564-20569
22. Cadas, H., Gaillet, S., Beltramo, M., Venance, L., and Piomelli, D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP J. Neurosci. 16, 3934-3942
23. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechaulam, R. (1992) Isolation and structure of a brain constitutent that binds to the cannabinoid receptor Science 258, 1946-1949
24. Stella, N., Schweitzer, P., and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation Nature 388, 773-778
25. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215, 89-97
26. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372, 686-691
27. Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi-Agro, A., Hillard, C., and Di Marzo, V. (2001) The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors Eur. J. Biochem. 268, 1982-1989
28. Desarnaud, F., Cadas, H., and Piomelli, D. (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization J. Biol. Chem. 270, 6030-6035
29. Egertová, M., Giang, D. K., Cravatt, B. F., and Elphick, M. R. (1998) A new perspective on cannabinoid signaling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain Proc. R. Soc. London Biol. Sci. 265, 2081-2085
30. 8- tetrahydrocannabinoldimethylheptyl to inhibit aenylate cyclase and bind to the cannabinoid receptor Neuropharmacology 29, 161-165
31. Johnson, M. R., Melvin, L. S., Althuis, T. H., Bindra, J. S., Harbert, C. A., Milne, G. M., and Weissman, A. (1981) Selective and potent analgetics derived from cannabinoids J. Clin. Pharmacol. 21, 271S-282S
32. Little, P. J., Compton, D. R., Johnson, M. R., Melvin, L. S., and Martin, B. R. (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J. Pharmacol. Exp. Ther. 247, 1046-1051
33. Luk, T., Jin, W., Zvonok, A., Lu, D., Lin, X.-Z., Chavkin, C., Makriyannis, A., and Mackie, K. (2004) Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist Br. J. Pharmacol. 142, 495-500
34. Pacheco, M., Childers, S. R., Arnold, R., Casiano, F., and Ward, S. J. (1991) Aminoalkylindoles: actions on specific G-protein-linked receptors J. Pharmacol. Exp. Ther. 257, 170-183
35. Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., and Seltzman, H. H. (1998) Comparative receptor binding analyses of cannabinoid agonists and antagonists J. Pharmacol. Exp. Ther. 285, 285-292
36. De Vry, J. and Jentzsch, K. R. (2003) Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm Behav. Pharmacol. 14, 471-476
37. McGregor, I. S., Issakidis, C. N., and Prior, G. (1996) Aversive effects of the synthetic cannabinoid CP 55,940 in rats Pharm. Biochem. Behav. 53, 657-664
38. Murray, J. E., Wells, N. R., Lyford, G. D., and Bevins, R. A. (2009) Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats Psychopharmacology 205, 655-665
39. Mechoulam, R., Feigenbaum, J. J., Lander, N., Segal, M., Jarbe, T. U. C., Hiltunen, A. J., and Consroe, P. (1988) Enantiomeric cannabinoids: stereospecificity of psychotropic activity Experientia 44, 762-764
40. Rodríguez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., and Weiss, F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal Science 276, 2050-2054
41. Castanñé, A., Maldonado, R., and Valverde, O. (2004) Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice Br. J. Pharmacol. 142, 1309-1317
42. Hampson, R. E. and Deadwyler, S. A. (2000) Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats J. Neurosci. 20, 8932-8942
43. Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., and Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277, 1094-1097
44. Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., La Rana, G., Russo, R., Calignano, A., Gessa, G. L., Cuomo, V., and Piomelli, D. (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404 Neuropsychopharmacology 31, 2652-2659
45. Vlachou, S., Stamatopoulou, F., Nomikos, G. G., and Panagis, G. (2008) Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine Int. J. Neuropsychopharmacol. 11, 905-923
46. Dalley, J. W. and Everitt, B. J. (2009) Dopamine receptors in the learning, memory and drug reward circuitry Semin. Cell Dev. Biol. 20, 403-410
47. Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., and Lecca, D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection Neuropharmacology 47, 227-241
48. Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006) Neural mechanisms of addiction: the role of reward-related learning and memory Annu. Rev. Neurosci. 29, 565-598
49. Wise, R. A. (2005) Forebrain substrates of reward and motivation J. Comp. Neurol. 493, 115-121
50. Everitt, B. J. and Robbins, T. W. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat. Neurosci. 8, 1481-1487
51. Wise, R. A. and Rompre, P.-P. (1989) Brain dopamine and reward Annu. Rev. Psychol. 40, 191-225
52. Carelli, R. M. and Ijames, S. G. (2000) Nucleus accumbens cell firing during maintenance, extinction, and reinstatement of cocaine self-administration behavior in rats Brain Res. 866, 44-54
53. Di Chiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U.S.A. 85, 5274-5278
54. Duvauchelle, C. L., Ikegami, A., and Castaneda, E. (2000) Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine Behav. Neurosci. 114, 1156-1166
55. Schultz, W., Dayan, P., and Montague, P. R. (1997) A neural substrate of prediction and reward Science 275, 1593-1599
56. Sombers, L. A., Beyene, M., Carelli, R. M., and Wightman, R. M. (2009) Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area J. Neurosci. 11, 1735-1742
57. Weiss, F., Lorang, M. T., Bloom, F. E., and Koob, G. F. (1993) Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants J. Pharmacol. Exp. Ther. 267, 250-258
58. Caine, S. B. and Koob, G. F. (1994) Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food J. Exp. Anal. Behav. 61, 213-221
59. Pettit, H. O., Ettenberg, A., Bloom, F. E., and Koob, G. F. (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats Psychopharmacology 84, 167-173
60. Gremel, C. M. and Cunningham, C. L. (2008) Roles of the nucleus accumbens and amygdale in the acquisition and expression of ethanol-conditioned behavior in mice J. Neurosci. 28, 1076-1084
61. Sellings, L. H. L. and Clarke, P. B. S. (2003) Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core J. Neurosci. 23, 6295-6303
62. Fleckenstein, A. E., Gibb, J. W., and Hanson, G. R. (2000) Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity Eur. J. Pharmacol. 406, 1-13
63. Dani, J. A. and De Biasi, M. (2001) Cellular mechanisms of nicotine addiction Pharmacol., Biochem. Behav. 70, 439-446
64. Placzek, A. N. and Dani, J. A. (2008) Synaptic Plasticity within Midbrain Dopamine Centers Contributes to Nicotine Addiction, in Nebraska Symposium on Motivation, Volume 55: The Motivational Impact of Nicotine and its Role in Tobacco Use (Bevins, R. A. and Caggiula, A. R., Eds.), pp 5 - 15, Springer, New York.
65. Spanagel, R. and Weiss, F. (1999) The dopamine hypothesis of reward: past and current status Trends Neurosci. 22, 521-527
66. Shippenberg, T. S., LeFevour, A., and Chefer, V. I. (2008) Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction CNS Neurol, Disord.: Drug Targets 7, 442-453
67. Cheer, J. F., Marsden, C. A., Kendall, D. A., and Mason, R. (2000) Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study Neuroscience 99, 661-667
68. French, E. D., Dillon, K., and Wu, X. (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra NeuroReport 8, 649-652
69. 1 receptors Eur. J. Pharmacol. 341, 39-44
70. 1 opioid receptor mechanism Science 276, 2048-2050
71. 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors Neurosci. Lett. 226, 159-162
72. Schlicker, E. and Kathmann, M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors Trends Pharmacol. Sci. 22, 565-572
73. Matsuda, L. A., Bonner, T. I., and Lolait, S. J. (1993) Localization of cannabinoid receptor mRNA in rat brain J. Comp. Neurol. 327, 535-550
74. Manzoni, O. J. and Bockaert, J. (2001) Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens Eur. J. Pharmacol. 412, R3-R5
75. Szabo, B., Siemes, S., and Wallmichrath, I. (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids Eur. J. Neurosci. 15, 2057-2061
76. Gardner, E. L. (2002) Addictive potential of cannabinoids: the underlying neurobiology Chem. Phys. Lipids 121, 267-290
77. Gardner, E. L. and Vorel, S. R. (1998) Cannabinoid transmission and reward-related events Neurobiol. Dis. 5, 502-533
78. Lupica, C. R. and Riegel, A. C. (2005) Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction Neuropharmacology 48, 1105-1116
79. Maldonado, R., Valverde, O., and Berrendero, F. (2006) Involvement of the endocannabinoid system in drug addiction Trends Neurosci. 29, 225-232
80. Pavlov, I. P. (1927) Conditioned Reflexes, Oxford University Press, London.
81. Tzschentke, T. M. (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues Prog. Neurobiol. 56, 613-672
82. Braida, D., Pozzi, M., Cavallini, R., and Sala, M. (2001) Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system Neuroscience 104, 923-926 (Pubitemid 32701955)
83. Polissidis, A., Chouliara, O., Galanopoulos, A., Marselos, M., Papadopoulou-Daifoti, Z., and Antoniou, K. (2009) Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure Life Sci. 85, 248-254
84. Pandolfo, P., Vendruscolo, L. F., Sordi, R., and Takahashi, R. N. (2009) Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat: an animal model of attention deficit hyperactivity disorder Psychopharmacology 205, 319-326
85. Allison, J., Larson, D., and Jensen, D. D. (1967) Acquired fear, brightness preference, and one-way shuttlebox performance Psychonomic Sci. 8, 269-270
86. Ghozland, S., Matthews, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., and Maldonado, R. (2002) Motivational effects of cannabinoids are mediated by Î-opioid and Î-opioid receptors J. Neurosci. 22, 1146-1154
87. Valjent, E. and Maldonado, R. (2000) A behavioural model to reveal place preference to Î9-tetrahydrocannabinol in mice Psychopharmacology 147, 436-438
88. Cunningham, C. L., Ferree, N. K., and Howard, M. A. (2003) Apparatus bias and place conditioning with ethanol in mice Psychopharmacology 170, 409-422
89. Roma, P. G. and Riley, A. L. (2005) Apparatus bias and the use of light and texture in place conditioning Pharmacol., Biochem. Behav. 82, 163-169
90. Burkey, T. H., Quock, R. M., Consroe, P., Ehlert, F. J., Hosohata, Y., Roeske, W. R., and Yamamura, H. I. (1997) Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain Eur. J. Pharmacol. 336, 295-298
91. 35S]GTPÎS autoradiography in rat brain J. Neurosci. 16, 8057-8066
92. 35S]GTPÎS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity J. Biol. Chem. 273, 16865-16873
93. Hillard, C. J. (2000) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol Prostaglandins Other Lipid Mediators 61, 3-18
94. Cheer, J. F., Kendall, D. A., and Mardsen, C. A. (2000) Cannabinoid receptors and reward in the rat: a conditioned place preference study Psychopharmacology 151, 25-30
95. 9- tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance Life Sci. 62, 2431-2439
96. 9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats Eur. J. Pharmacol. 506, 63-69
97. 9- tetrahydrocannabinol: comparison with cocaine, morphine, and food reward Life Sci. 56, 2073-2080
98. Lemberger, L., McMahon, R. E., Archer, R. A., Matsumoto, K., and Rowe, H. (1973) The in vitro and in vivo metabolism of Î6a, 10a dimethyl heptyl tetrahydrocannabinol (DMHP) J. Pharmacol. Exp. Ther. 187, 169-175
99. 1 receptor ligand Life Sci. 58, 1249-1257
100. Scherma, M., Medalie, J., Fratta, W., Vadivel, S. K., Makriyannis, A., Piomelli, D., Mikics, E., Haller, J., Yasar, S., Tanda, G., and Goldberg, S. R. (2008) The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition Neuropharmacology 54, 129-140
101. 2A receptors are involved in physical dependence and place conditioning induced by Î9-THC Eur. J. Neurosci. 20, 2203-2213
102. Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., and Maldonado, R. (2001) Absence of Î-9- tetrahydrocannabinol dysphoric effects on dynorphin-deficient mice J. Neurosci. 21, 9499-9505
103. Cheng, H.-Y. M., Laviolette, S. R., van der Kooy, D., and Penninger, J. M. (2004) DREAM ablation selectively alters Î9-THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine Eur. J. Neurosci. 19, 3033-3041
104. Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., and Maldonado, R. (1998) Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Î-9- tetrahydrocannabinol Br. J. Pharmacol. 125, 1567-1577
105. 9-tetrahydrocannabinol Drug Alcohol Depend. 94, 191-198
106. 9-THC exposure when immature or during early adulthood Psychopharmacologia 34, 181-190
107. Lamb, R. J., Jarbe, T. U. C., Makriyannis, A., Lin, S., and Goutopoulos, A. (2000) Effects of Î9-tetrahydrocannabinol, (R)-methanandamide, SR 141716, and d -amphetamine before and during daily Î9-tetrahydrocannabinol dosing Eur. J. Pharmacol. 398, 251-258
108. 9-tetrahydrocannabinol behavioural sensitization Eur. J. Neurosci. 17, 325-330
109. Wiley, J. L., Evans, R. L., Grainger, D. B., and Nicholson, K. L. (2008) Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs in male adolescent and adult rats Addict. Biol. 13, 277-286
110. 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents Behav. Pharmacol. 18, 311-319
111. Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., and Chapman, V. (2009) Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol. Pain [Online eraly access] DOI: 10.1186/1744-8069-5-59.
112. Cavuoto, P. and Wittert, G. A. (2009) The role of the endocannabinoid system in the regulation of energy expenditure Best Pract. Res. Clin. Endocrinol. Metab. 23, 79-86
113. Slatkin, N. E. (2007) Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis J. Support. Oncol. 5, 1-9
114. Hill, M. N., Hillard, C. J., Bambico, F. R., Patel, S., Gorzalka, B. B., and Gobbi, G. (2009) The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants Trends Pharmacol. Sci. 30, 484-493
115. Célérier, E., Ahdepil, T., Wikander, H., Berrendero, F., Nyberg, F., and Maldonado, R. (2006) Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence Neuropharmacology 50, 788-806
116. Robledo, P., Trigo, J. M., Panayi, F., de la Torre, R., and Maldonado, R. (2007) Behavioural and neurochemical effects of combined MDMA and Î9-THC administration in mice Psychopharmacology 195, 255-264
117. Valjent, E., Pages, C., Rogard, M., Besson, M.-J., Maldonado, R., and Caboche, J. (2001) Î9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission Eur. J. Neurosci. 14, 342-352
118. Valjent, E., Mitchell, J. M., Besson, M.-J., Caboche, J., and Maldonado, R. (2002) Behavioural and biochemical evidence for interactions between Î9-tetrahydrocannabinol and nicotine Br. J. Pharmacol. 135, 564-578
119. Le Foll, B., Wiggins, M., and Goldberg, S. R. (2006) Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Î-9-tetrahydrocannabinol in rats Behav. Pharm. 17, 195-199
120. Ji, S.-P., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., and Zhang, X. (2006) Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse Nat. Med. 12, 324-329
121. Sanñudo-Penña, M. C., Tsou, K., Delay, E. R., Hohman, A. G., Force, M., and Walker, J. M. (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat Neurosci. Lett. 223, 125-128
122. Parker, L. A. and Gillies, T. (1995) Î9-THC-induced place and taste aversions in Lewis and Sprague-Dawley rats Behav. Neurosci. 109, 71-78
123. Manzanedo, C., Aguilar, M. A., Rodriguez-Arias, M., Navarro, M., and Minñarro, J. (2004) Cannabinoid agonist-induced sensitization to morphine place preference in mice NeuroReport 15, 1373-1377
124. López-Moreno, J. A., González-Cuevas, G., Rodríguez de Fonseca, F., and Navarro, M. (2004) Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation J. Neurosci. 24, 8245-8252
125. Chaperon, F., Soubrié, P., Puech, A. J., and Thiébot, M.-H. (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats Psychopharmacology 135, 324-332